Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/194933
Type: Artigo de periódico
Title: Delayed First Injection Of The Once-a-month Injectable Contraceptive Containing 25 Mg Medroxyprogesterone Acetate And 5 Mg Estradiol-cypionate: Effects On Cervical Mucus.
Author: Petta, C A
Hays, M
Brache, V
Massai, R
Hua, Y
Alvarez-Sánchez, F
Salvatierra, A
d'Arcangues, C
Cook, L A
Bahamondes, L
Abstract: The objectives of this study were to assess whether women who were administered the first injection of the once-a-month contraceptive containing estradiol cypionate and 25 mg depot-medroxyprogesterone acetate (MPA+E(2)C) on Day 7 of their menstrual cycle (delayed injection) exhibit the same degree of cervical mucus changes as women who receive it on Day 5 of their menstrual cycle. This was a multicenter, randomized, controlled clinical trial. A total of 158 women, aged between 18 and 38 years (inclusive), who, were willing to use MPA+E(2)C as their contraceptive method participated in the trial. Participants received a MPA+E(2)C injection on Day 5 (control group, n = 41) or Day 7 (delayed-injection group, n = 117) of their menstrual cycle. Participants who received MPA+E(2)C on Day 5 of their menstrual cycle (control group) exhibited fair or poor mucus quality and poor sperm penetration. Of those women who received MPA+E(2)C on Day 7 of their menstrual cycle (delayed-injection group), 3 (3%) showed good mucus or good sperm penetration at some time point during follow-up. It is possible to conclude that the first injection of MPA+E(2)C given on Day 7 of a menstrual cycle does not provide the same degree of inhibition of mucus quality and sperm penetration as that observed if it is administered on Day 5. However, the theoretical risk of pregnancy after receiving MPA+E(2)C on Day 7 would be expected to be low.
Subject: Adult
Cervix Mucus
Contraceptive Agents, Female
Contraceptives, Oral, Combined
Delayed-action Preparations
Drug Administration Schedule
Estradiol
Female
Humans
Injections, Intramuscular
Medroxyprogesterone Acetate
Ovary
Sperm-ovum Interactions
Time Factors
Citation: Contraception. v. 64, n. 6, p. 363-8, 2001-Dec.
Rights: fechado
Address: http://www.ncbi.nlm.nih.gov/pubmed/11834235
Date Issue: 2001
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
pmed_11834235.pdf50.85 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.